Cardinal Health Recalls Levofloxacin Injection Due to Temperature Excursions
Cardinal Health Inc. is recalling 35 bags of Levofloxacin Injection due to intermittent temperature excursions during storage.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. Per the rubric, FDA Class II recalls are assigned a severity score of 4 (Severe), as they may cause temporary or medically reversible adverse health consequences.
Plain-English summary
Cardinal Health Inc. is recalling 35 bags of Levofloxacin Injection in 5% Dextrose 500 mg in 100 mL 5% Dextrose (5 mg/mL) 24x100 mL Single Dose Flexible Containers. The product is identified by NDC 0143-9721-24 and code 2007046.1. The recall was initiated because of intermittent exposure to temperature excursions during storage, which constitutes a Current Good Manufacturing Practice (CGMP) deviation.
The affected product was distributed to facilities in Florida, Georgia, and South Carolina. The recall is classified as FDA Class II, indicating a situation where use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
Healthcare providers and facilities in the affected states should check their inventory for the specific NDC and code listed above. If the product is found, it should be quarantined and not administered to patients. Consumers should contact their healthcare provider if they have received this specific medication.
The recalled product
- Product
- LEVOFLOXACIN (LEVOFLOXACIN)
- Brand
- LEVOFLOXACIN
- Manufacturer
- Cardinal Health Inc.
- Category
- Drug — Antibiotic Injection
- Affected units
- 35
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- 2007046.1
Distribution
Part of a larger recall action
This product is one of 198 recalled by Cardinal Health Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 198 products in this recall →Related recalls
Same brand · LEVOFLOXACIN
- HighLevofloxacin 500 mg Tablets Recalled Due to Manufacturing Temperature Abuse
FDA (Drugs) · 2022-06-15
- ModerateBaxter Recalls Levofloxacin Injection Bags Due to High Potency
FDA (Drugs) · 2018-10-03
- ModerateBaxter Recalls Levofloxacin Injection Due to High Concentration Levels
FDA (Drugs) · 2018-08-15
- ModerateBaxter Recalls Levofloxacin Injection Due to High Potency Levels
FDA (Drugs) · 2018-08-15
- LowBaxter Recalls Levofloxacin Injection Due to High Potency Levels
FDA (Drugs) · 2018-08-15
Same manufacturer · Cardinal Health Inc.
See all →- HighEnoxaparin syringe bags recalled after being labeled with the wrong strength
FDA (Drugs) · 2025-09-03
- ModerateXolair auto-injectors exposed to temperatures outside labeled storage requirements
FDA (Drugs) · 2025-08-13
- ModerateRecombinate antihemophilic factor vials exposed to temperatures outside labeled storage
FDA (Drugs) · 2025-08-13
- ModerateXolair 75 mg syringes exposed to temperatures outside labeled storage requirements
FDA (Drugs) · 2025-08-13
- ModerateWegovy injection recalled due to temperature exposure during shipping
FDA (Drugs) · 2025-05-07
Same hazard · temperature excursion
See all →- ModerateCyclophosphamide injection vials recalled after a transportation temperature excursion
FDA (Drugs) · 2025-09-24
- ModerateProlia prefilled syringes recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateBenlysta vials recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateEvenity prefilled syringes recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30